Humana (HUM)
(Delayed Data from NYSE)
$387.38 USD
-1.51 (-0.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $387.35 -0.03 (-0.01%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
HUM 387.38 -1.51(-0.39%)
Will HUM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HUM
Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
UnitedHealth Group (UNH) Beats Q2 Earnings and Revenue Estimates
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth (UNH) Pre-Q2 Earnings: Healthy Buy or a Wait-&-See?
Company News for Jul 5, 2024
Humana (HUM) Ties Up With PsychArmor for Better Veteran Care
Other News for HUM
Should You Buy Humana Stock Right Now? Here’s What Piper Sandler Expects
Dividend Champion, Contender, And Challenger Highlights: Week Of July 21
Class Action Lawsuit Against Humana Inc. (NYSE:HUM)
Humana Accelerates Commitment to Helping Seniors Choose Right Health Plan, Announces Minority Investment in Healthpilot
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration